Alembic Pharmaceuticals informs about press release

20 Feb 2019 Evaluate

Alembic Pharmaceuticals has informed that the Company has received US Food & Drug Administration (USFDA) Approval for Acetazolamide Extended-Release Capsules, 500 mg. Further, the company has submitted its press release.

The above information is a part of company’s filings submitted to BSE.

Alembic Pharma Share Price

647.80 1.55 (0.24%)
24-Mar-2026 12:05 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1768.10
Dr. Reddys Lab 1262.90
Cipla 1230.00
Zydus Lifesciences 878.20
Lupin 2313.00
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×